Fig 1: Cardiac ATF3, NCOA4-mediated ferritinophagy, and ferrous iron content among different studied groups. (A) Cardiac ATF3 (ng/mg tissue protein). (B) NCOA4 relative gene expression. (C) Cardiac Fe2+ (mg/mg tissue protein). CON, control; DOX, doxorubicin; DCN-L, diacerein low dose; DCN-H, diacerein high dose; ATF3, activating transcription factor 3; NCOA4, nuclear receptor co-activator 4. p < 0.05, values expressed as mean ± SD (n = 7), * significant vs. CON group, # significant vs. DOX group, & significant vs. DCN-L+DOX group.
Fig 2: Correlation between cardiac NRF2 and other measured parameters in the DCN high-dose-treated group. (A) CK-MB activity (U/L). (B) cTn-I levels (pg/mL). (C) LDH activity (U/L). (D) ATF3 level (ng/mg protein). (E) NCOA4 mRNA level. (F) Fe2+ (mg/mg protein). (G) 4-HNE (ng/g tissue). (H) GSH content (mg/g tissue). (I) HMGB1 (ng/mL) in the high-dose DCN-treated group.
Supplier Page from MyBioSource.com for Rat Activating Transcription Factor 3 ELISA Kit